KR102450185B1 - Method for extracting active ingredients from Ulmi Cortex - Google Patents

Method for extracting active ingredients from Ulmi Cortex Download PDF

Info

Publication number
KR102450185B1
KR102450185B1 KR1020220081702A KR20220081702A KR102450185B1 KR 102450185 B1 KR102450185 B1 KR 102450185B1 KR 1020220081702 A KR1020220081702 A KR 1020220081702A KR 20220081702 A KR20220081702 A KR 20220081702A KR 102450185 B1 KR102450185 B1 KR 102450185B1
Authority
KR
South Korea
Prior art keywords
milkweed
extract
extracting
content
extraction
Prior art date
Application number
KR1020220081702A
Other languages
Korean (ko)
Inventor
강현
Original Assignee
단국대학교 천안캠퍼스 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 단국대학교 천안캠퍼스 산학협력단 filed Critical 단국대학교 천안캠퍼스 산학협력단
Priority to KR1020220081702A priority Critical patent/KR102450185B1/en
Application granted granted Critical
Publication of KR102450185B1 publication Critical patent/KR102450185B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a method for extracting an active component of Ulmus pumila comprising the following steps: preparing Ulmus pumila; extracting a solution containing an active component by mixing the prepared Ulmus pumila with an organic solvent; and concentrating and freeze-drying the extracted solution under reduced pressure to manufacture an Ulmus pumila extract.

Description

유백피로부터 유효성분을 추출하는 방법{Method for extracting active ingredients from Ulmi Cortex}Method for extracting active ingredients from milk white skin {Method for extracting active ingredients from Ulmi Cortex}

본 발명은 유백피로부터 유효성분을 추출하는 방법에 관한 것이다.The present invention relates to a method for extracting an active ingredient from milky white skin.

느릅나무과(Ulmaceae)에 속하는 유백피(Ulmi Cortex)는 느릅나무의 수피 또는 근피로써, 예로부터 수욕, 거담, 항암, 항부패성, 상처치료약 및 염증에도 탁월한 효과가 있다고 보고 되었으며, 유백피 중에는 β-sitosterol, phytosterol, stimasterol, tannin, starch, polysaccharide 등이 존재하고, 또한 진통작용을 나타내는 성분인 frieselin과 epifriendelalol, taraxerol 등의 분리와 화학적 조성에 관한 연구 등이 많이 이루어져 있으나 유백피의 다양한 생리활성을 연구한 시도는 아직 거의 이루어지지 않았다. Ulmi Cortex belonging to the family Ulmaceae is the bark or root bark of elm, and has been reported to have excellent effects in water bathing, expectoration, anticancer, anti-corrosive properties, wound healing agents and inflammation. Sitosterol, phytosterol, stimasterol, tannin, starch, polysaccharide, etc. exist, and there have been many studies on the separation and chemical composition of frieselin, epifriendelalol, and taraxerol, which are components that exhibit analgesic action. Attempts have yet to be made.

한편, Superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT), glutathione reductase, glutathione-S-transferase 등과 같이 인체 내에는 활성산소에 방어하는 항산화 효소를 가지고 있지만 산업화와 더불어 증가되는 각종 환경오염 물질, 흡연, 스트레스 등에 의해 인체 내의 항산화계의 역할만으로는 방어 체계가 초과되어 단백질 분해, DNA 손상 등이 유발된다.On the other hand, although it has antioxidant enzymes that protect against free radicals in the human body, such as superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT), glutathione reductase, and glutathione-S-transferase, various environmental pollution that is increasing with industrialization Due to substances, smoking, and stress, the role of the antioxidant system in the human body alone exceeds the defense system, causing protein degradation and DNA damage.

따라서, 항산화제로 butylated hydroxyanisole (BHA)과 butylated hydroxytoluene(BHT)와 같은 합성물질들이 개발되었으나, 이들의 경우 다량을 섭취하면 여러 가지 부작용을 나타낼 수 있어 천연으로부터 안전한 식이성 항산화물질을 찾는 연구가 활발히 진행되고 있다.Therefore, synthetic substances such as butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) have been developed as antioxidants. is becoming

한편, 염증은 감염으로 인한 인체 조직손상을 막는 방어기전으로 발전, 발열, 통증과 같은 증상을 수반한다. 이러한 염증반응이 장기간 지속적으로 반복될 경우 신경퇴행성질환과 같은 각종 만성질환과 암 등을 발병할 수 있는 요인이 된다.On the other hand, inflammation is a defense mechanism that prevents damage to human tissue due to infection and is accompanied by symptoms such as development, fever, and pain. If this inflammatory response is repeated for a long time, it becomes a factor that can cause various chronic diseases such as neurodegenerative diseases and cancer.

대식세포(macrophage)는 인체 내 면역반응에서 일산화질소(nitric oxide; NO)와 프로스타글란딘(prostaglandin; PG)과 pro-inflammatory cytokine 등과 같은 염증매개물질 생성에 관여하고 이를 조절한다. 이러한 염증매개물질은 염증반응을 유도하며, 숙주의 면역반응이 적절하게 대응하지 못할 경우 염증성 질환을 유발한다.Macrophages are involved in and regulate the production of inflammatory mediators such as nitric oxide (NO), prostaglandin (PG), and pro-inflammatory cytokines in the immune response in the body. These inflammatory mediators induce an inflammatory response, and when the host's immune response does not respond properly, it causes inflammatory diseases.

한편, 생리활성이 우수한 소재를 산업적 소재로 활용하기 위해서는 생리활성에 대한 탐색과 별도로 소재의 특징을 고려한 최적의 제조공정에 관한 연구 및 검토가 요구되고 있다. 생물소재는 생산과정 중 한계를 가지고 있어 적은 공간과 낮은 비용으로 다량의 기능성 물질을 생산할 수 있어야 하며, 저렴한 비용으로 동일한 양의 생물소재로부터 가급적 다량의 유용물질을 생산할 수 있는 추출공정개발이 필요하다.On the other hand, in order to utilize a material with excellent physiological activity as an industrial material, research and review on the optimal manufacturing process considering the characteristics of the material is required separately from the search for physiological activity. Biological materials have limitations during the production process, so it is necessary to produce a large amount of functional materials with a small space and low cost, and it is necessary to develop an extraction process that can produce as much useful material as possible from the same amount of biological material at a low cost. .

특허문헌 1: 대한민국공개특허 10-2018-0106104Patent Document 1: Republic of Korea Patent Publication 10-2018-0106104

이에, 본 발명자들은 유백피로부터 주요성분을 효과적으로 추출하는 방법을 제공하고자 노력한 결과, 추출공정, 공정온도, 추출용매, 첨가제에 대해 최적화를 수행하여 주요성분 및 활성성분인 폴리페놀 및 플라보노이드의 추출량을 향상시킬 수 있음을 발견하고 본 발명을 완성하였다.Accordingly, the present inventors have tried to provide a method for effectively extracting the main ingredients from the milkweed, and as a result, the extraction process, process temperature, extraction solvent, and additives were optimized to determine the extraction amount of polyphenols and flavonoids, which are the main ingredients and active ingredients. It has been found that improvements can be made and the present invention has been completed.

삭제delete

상기 목적을 달성하기 위하여 본 발명은In order to achieve the above object, the present invention

유백피를 준비하는 단계;Preparing milk white blood;

준비된 유백피를 유기 용매와 혼합하여 유효성분을 포함하는 용액을 추출하는 단계; 및Extracting a solution containing an active ingredient by mixing the prepared milkweed with an organic solvent; and

추출된 용액을 감압농축 및 동결건조하여 유백피 추출물을 제조하는 단계;를 포함하는 유백피 유효성분 추출방법을 제공한다.Concentrating the extracted solution under reduced pressure and freeze-drying to prepare a milkweed extract; provides a method for extracting milkweed active ingredients comprising.

또한, 상기 유효성분을 포함하는 용액을 추출하는 단계는 준비된 유백피를 유기 용매 및 공융 용매와 혼합하여 수행되는 것이고, 상기 유기 용매는 아세톤 및 클로로포름을 1:1의 부피비로 혼합한 것이고, 상기 공융 용매는 염으로 콜린클로라이드 및 수소결합주개로 에틸렌글리콜을 1:4의 몰비로 혼합한 것이고, In addition, extracting the solution containing the active ingredient is performed by mixing the prepared milkweed with an organic solvent and a eutectic solvent, and the organic solvent is a mixture of acetone and chloroform in a volume ratio of 1:1, and the eutectic The solvent is a mixture of choline chloride as a salt and ethylene glycol as a hydrogen bond donor in a molar ratio of 1:4,

상기 추출은 초음파공정으로 30℃의 온도에서 24시간 동안 수행되는 것을 특징으로 한다.The extraction is characterized in that the ultrasonic process is performed for 24 hours at a temperature of 30 ℃.

삭제delete

본 발명에 따른 유백피 추출물은 총 폴리페놀 함량 167.54 mg/g, 총 플라보노이드 함량 25.31 mg/g으로 매우 높은 주요성분의 함량을 나타낸다.Milkweed extract according to the present invention shows a very high content of major components with a total polyphenol content of 167.54 mg/g and a total flavonoid content of 25.31 mg/g.

본 발명은the present invention

유백피를 준비하는 단계;Preparing milk white blood;

준비된 유백피를 유기 용매와 혼합하여 유효성분을 포함하는 용액을 추출하는 단계; 및Extracting a solution containing an active ingredient by mixing the prepared milkweed with an organic solvent; and

추출된 용액을 감압농축 및 동결건조하여 유백피 추출물을 제조하는 단계;를 포함하는 유백피 유효성분 추출방법을 제공한다.Concentrating the extracted solution under reduced pressure and freeze-drying to prepare a milkweed extract; provides a method for extracting milkweed active ingredients comprising.

이하, 본 발명에 따른 유백피 유효성분 추출방법에 대하여 상세히 설명한다.Hereinafter, the method for extracting the active ingredient of milk white skin according to the present invention will be described in detail.

먼저, 본 발명에 따른 유백피 유효성분 추출방법은 유백피를 준비하는 단계를 포함한다.First, the method for extracting milky white skin active ingredient according to the present invention includes the step of preparing the milky white skin.

상기 단계에서는 유백피를 적절한 크기로 자른 뒤 동결 건조시키고, 믹서기로 갈아서 분말 형태로 준비할 수 있다.In the above step, after cutting the milkweed to an appropriate size, freeze-drying, and grinding with a blender can be prepared in powder form.

다음으로, 본 발명에 따른 유백피 유효성분 추출방법은 준비된 유백피를 유기 용매와 혼합하여 유효성분을 포함하는 용액을 추출하는 단계를 포함한다.Next, the method for extracting the active ingredient of milkweed according to the present invention comprises the step of extracting a solution containing the active ingredient by mixing the prepared milkweed with an organic solvent.

상기 단계에서는 준비된 유백피를 유기 용매와 혼합하여 유효성분을 포함하는 용액을 추출하는 것으로, 유백피의 추출물에서 추출되는 유효성분 및/또는 활성성분을 늘리는 것이 수행되어야 하며, 유기 용매(또는 추출용매)의 종류, 이와 혼합되는 첨가제의 종류와 함량, 추출공정, 공정온도가 주요 조건이 될 수 있다.In the above step, to extract a solution containing the active ingredient by mixing the prepared milkweed with an organic solvent, increasing the active ingredient and/or active ingredient extracted from the extract of the milkweed should be performed, and an organic solvent (or extraction solvent) The type and content of additives mixed therewith, extraction process, and process temperature can be the main conditions.

상기 유기 용매(또는 추출용매)는 메탄올, 에탄올, 아세톤, 클로로포름, 에틸렌클로라이드, 에틸아세테이트, n-헥산, 디클로로메탄 등을 사용할 수 있으며, 바람직하게는 아세톤 및 클로로포름을 1:1의 부피비로 혼합한 것을 사용할 수 있다.As the organic solvent (or extraction solvent), methanol, ethanol, acetone, chloroform, ethylene chloride, ethyl acetate, n-hexane, dichloromethane, etc. may be used, and preferably acetone and chloroform are mixed in a volume ratio of 1:1. that can be used

상기 추출은 디핑공정, 초음파공정, 환류공정 등으로 수행될 수 있으며, 바람직하게는 초음파공정을 통해 추출을 수행할 수 있다.The extraction may be performed by a dipping process, an ultrasonic process, a reflux process, etc., and preferably, the extraction may be performed through an ultrasonic process.

상기 추출은 20-40℃의 온도범위에서 24시간 동안 수행될 수 있으며, 바람직하게는 30℃의 온도에서 24시간 동안 수행될 수 있다.The extraction may be performed for 24 hours at a temperature range of 20-40 °C, preferably at a temperature of 30 °C for 24 hours.

상기 추출을 위해서 첨가제로서 공융용매를 사용할 수 있으며, 상기 공융용매는 염과 수소결합주개를 포함한다. 상기 공융용매에서 염은 콜린클로라이드(choline chloride, ChCl), 테트라메틸암모늄클로라이드(Tetramethylammonium chloride, Me4NCl), 메틸 트리페닐 포스포늄 브로마이드(Methyl triphenyl phosphonium bromide, Me(Ph)3PBr) 등을 사용할 수 있으며, 바람직하게는 콜린클로라이드를 사용할 수 있다. 상기 공융용매에서 수소결합주개는 에틸렌글리콜(Ethylene glycol), 1,2-부탄디올(1,2-Butanediol), 페놀(Phenol), 우레아(Urea) 등을 사용할 수 있으며, 바람직하게는 에틸렌글리콜을 사용할 수 있다. 상기 유백피의 추출을 위해서 바람직하게는 콜린클로라이드 및 에틸렌 글라이콜을 1:4의 몰비로 혼합하여 사용할 수 있다.For the extraction, a eutectic solvent may be used as an additive, and the eutectic solvent includes a salt and a hydrogen bond donor. The salt in the eutectic solvent is choline chloride (ChCl), tetramethylammonium chloride (Tetramethylammonium chloride, Me4NCl), methyl triphenyl phosphonium bromide (Methyl triphenyl phosphonium bromide, Me (Ph) 3 PBr) and the like can be used, Preferably, choline chloride may be used. In the eutectic solvent, as the hydrogen bond donor, ethylene glycol, 1,2-butanediol, phenol, urea, etc. may be used, and preferably ethylene glycol may be used. can Preferably, choline chloride and ethylene glycol may be mixed in a molar ratio of 1:4 for extraction of the milkweed.

상기 공융 용매의 함량은 유기 용매 1 ml에 대하여 0.01-1.0 g일 수 있으며, 바람직한 일례로 상기 공융 용매의 함량은 유기 용매 1 ml에 대하여 0.6 g을 사용할 수 있다.The content of the eutectic solvent may be 0.01-1.0 g per 1 ml of the organic solvent, and in a preferred example, the content of the eutectic solvent may be 0.6 g per 1 ml of the organic solvent.

다음으로, 본 발명에 따른 유백피 유효성분 추출방법은 추출된 용액을 감압농축 및 동결건조하여 유백피 추출물을 제조하는 단계를 포함한다.Next, the method for extracting milky white skin active ingredient according to the present invention includes the step of concentrating the extracted solution under reduced pressure and freeze-drying to prepare a milky white skin extract.

최종적으로 추출된 용액을 감압농축 및 동결건조하여 유백피 추출물을 제조하게 되며, 추출물을 여과지로 여과한 뒤 농축기로 55℃에서 감압농축 및 동결건조하는 것일 수 있다.Finally, the extracted solution is concentrated and freeze-dried under reduced pressure to prepare a milkweed extract, and the extract may be filtered with a filter paper and then concentrated under reduced pressure and freeze-dried at 55°C with a concentrator.

이를 통해 제조되는 유백피 추출물은 총 폴리페놀 함량 167.54 mg/g, 총 플라보노이드 함량 25.31 mg/g을 포함하는 것을 특징으로 한다.The milkweed extract prepared through this is characterized in that it contains a total polyphenol content of 167.54 mg/g and a total flavonoid content of 25.31 mg/g.

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

이하, 본 발명을 하기의 실시예에 의해 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail by way of the following examples.

단, 하기 실시예는 본 발명의 내용을 예시하는 것일 뿐 발명의 범위가 실시예 및 실험예에 의해 한정되는 것은 아니다.However, the following examples are merely illustrative of the content of the present invention, and the scope of the present invention is not limited by the examples and experimental examples.

<실시예 1> 유백피 추출물의 제조-1<Example 1> Preparation of milk white skin extract-1

유백피를 준비하여 동결건조 시킨 후, 믹서기로 갈아서 유백피 분말을 준비하였다. After preparing the milk white skin and freeze-drying, it was ground with a blender to prepare milk white skin powder.

준비된 유백피 분말 0.05 g를 유기 용매인 70% 에탄올 5 ml에 첨가하였다.0.05 g of the prepared milk powder was added to 5 ml of 70% ethanol as an organic solvent.

이후, 디핑(dipping), 초음파공정(ultra sonic) 및 환류(reflux) 공정을 수행하여 20-40℃의 온도에서 24시간 동안 추출한 후, 여과지(Watman No. 2)로 여과한 뒤 농축기(EYELA N-3000, Japan)로 55℃에서 감압농축 및 동결건조하여 추출물을 얻었다. 실시예 1에서 수행된 유백피 추출의 조건은 하기 표 1에 나타내었다.Then, dipping, ultrasonic processing (ultra sonic) and reflux (reflux) processes are performed to extract for 24 hours at a temperature of 20-40 ° C., and then filter with filter paper (Watman No. 2) and concentrator (EYELA N -3000, Japan) was concentrated under reduced pressure at 55 °C and freeze-dried to obtain an extract. The conditions for extracting milk white skin carried out in Example 1 are shown in Table 1 below.

제조된 유백피 추출물의 총 폴리페놀 함량 및 총 플라보노이드 함량을 분석하였으며, 구체적으로, 총 폴리페놀 함량은 Folin-Denis법을 응용하여 측정하였으며, 총 플라보노이드 함량은 Nieva Moreno 방법을 응용하여 측정하였고 그 결과를 하기 표 2에 나타내었다.The total polyphenol content and total flavonoid content of the prepared milkweed extract were analyzed. Specifically, the total polyphenol content was measured by applying the Folin-Denis method, and the total flavonoid content was measured by applying the Nieva Moreno method. is shown in Table 2 below.

실시예 1Example 1 추출용매extraction solvent 추출공정extraction process 공정온도 (℃)Process temperature (℃) 실시예 1-1Example 1-1 에탄올ethanol 디핑dipping 2020 실시예 1-2Example 1-2 초음파ultrasonic wave 2020 실시예 1-3Examples 1-3 환류reflux 2020 실시예 1-4Examples 1-4 초음파ultrasonic wave 1010 실시예 1-5Examples 1-5 초음파ultrasonic wave 3030 실시예 1-6Examples 1-6 초음파ultrasonic wave 4040

실시예 1Example 1 총 폴리페놀 함량
(mg/g)
Total polyphenol content
(mg/g)
총 플라보노이드 함량
(mg/g)
Total flavonoid content
(mg/g)
실시예 1-1Example 1-1 88.5288.52 14.2814.28 실시예 1-2Example 1-2 90.7090.70 14.8914.89 실시예 1-3Examples 1-3 86.2186.21 10.4710.47 실시예 1-4Examples 1-4 87.2287.22 12.5612.56 실시예 1-5Examples 1-5 91.3591.35 15.9015.90 실시예 1-6Examples 1-6 90.8690.86 14.2814.28

상기 표 1 및 표 2에 나타낸 바와 같이, 추출공정으로 초음파공정을 적용하고 공정온도로 30℃를 적용하는 경우 에탄올 추출용매 하에서 총 폴리페놀 함량 91.35 mg/g, 총 플라보노이드 함량 15.90 mg/g으로 우수한 추출효율을 나타냄을 확인할 수 있다.As shown in Table 1 and Table 2, when the ultrasonic process is applied as the extraction process and 30° C. is applied as the process temperature, the total polyphenol content is 91.35 mg/g and the total flavonoid content is 15.90 mg/g under the ethanol extraction solvent. It can be seen that the extraction efficiency is shown.

<실시예 2> 유백피 추출물의 제조-2<Example 2> Preparation of milkweed extract-2

유백피를 준비하여 동결건조 시킨 후, 믹서기로 갈아서 유백피 분말을 준비하였다.After preparing the milk white skin and freeze-drying, it was ground with a blender to prepare milk white skin powder.

준비된 유백피 분말 0.05 g를 에탄올, 메탄올, 아세톤, 클로로포름, 에틸렌클로라이드, n-헥산, 디클로로메탄 중 1종 이상을 포함하는 유기 용매 5 ml에 첨가하였다.0.05 g of the prepared milk powder was added to 5 ml of an organic solvent containing at least one of ethanol, methanol, acetone, chloroform, ethylene chloride, n-hexane, and dichloromethane.

이후, 초음파공정을 수행하여 30℃의 온도에서 24시간 동안 추출한 후, 여과지(Watman No. 2)로 여과한 뒤 농축기(EYELA N-3000, Japan)로 55℃에서 감압농축 및 동결건조하여 추출물을 얻었다. 실시예 2에서 수행된 유백피 추출의 조건은 하기 표 3에 나타내었다.Then, after performing an ultrasonic process to extract at a temperature of 30 ℃ for 24 hours, filtered with filter paper (Watman No. 2), concentrated under reduced pressure at 55 ℃ with a concentrator (EYELA N-3000, Japan) and freeze-dried to extract the extract got it The conditions for extracting milk white skin performed in Example 2 are shown in Table 3 below.

제조된 유백피 추출물의 총 폴리페놀 함량, 총 플라보노이드 함량을 분석하였으며, 구체적으로, 총 폴리페놀 함량은 Folin-Denis법을 응용하여 측정하였으며, 총 플라보노이드 함량은 Nieva Moreno 방법을 응용하여 측정하였고 그 결과를 하기 표 4에 나타내었다.The total polyphenol content and total flavonoid content of the prepared milkweed extract were analyzed. Specifically, the total polyphenol content was measured by applying the Folin-Denis method, and the total flavonoid content was measured by applying the Nieva Moreno method. is shown in Table 4 below.

실시예 2Example 2 추출용매extraction solvent 추출공정extraction process 공정온도 (℃)Process temperature (℃) *실시예 1-5*Examples 1-5 에탄올ethanol 초음파ultrasonic wave 3030 실시예 2-1Example 2-1 메탄올methanol 실시예 2-2Example 2-2 아세톤acetone 실시예 2-3Example 2-3 클로로포름chloroform 실시예 2-4Example 2-4 에틸렌클로라이드ethylene chloride 실시예 2-5Example 2-5 n-헥산n-hexane 실시예 2-6Example 2-6 디클로로메탄dichloromethane **실시예 2-7**Example 2-7 아세톤/클로로포름Acetone/Chloroform

* 실시예 1-5는 실시예 1에서 가져옴* Examples 1-5 are taken from Example 1.

** 실시예 2-7은 아세톤 및 크롤로포름을 1:1로 부피비로 혼합한 것임** Example 2-7 is a mixture of acetone and chloroform in a 1:1 volume ratio

실시예 2Example 2 총 폴리페놀 함량
(mg/g)
Total polyphenol content
(mg/g)
총 플라보노이드 함량
(mg/g)
Total flavonoid content
(mg/g)
실시예 1-5Examples 1-5 91.3591.35 15.9015.90 실시예 2-1Example 2-1 82.1882.18 14.2214.22 실시예 2-2Example 2-2 92.3792.37 16.3516.35 실시예 2-3Example 2-3 91.9091.90 16.0516.05 실시예 2-4Example 2-4 78.4178.41 10.4810.48 실시예 2-5Example 2-5 83.4883.48 11.5711.57 실시예 2-6Example 2-6 82.5982.59 10.9510.95 실시예 2-7Example 2-7 93.7593.75 16.8016.80

상기 표 3 및 표 4에 나타낸 바와 같이, 추출용매로로 에탄올, 아세톤 및 클로로포름을 적용하는 경우 우수한 추출효율을 나타냄을 확인할 수 있었다. 더욱이, 추출용매로 아세톤 및 클로로포름을 1:1의 부피비율로 혼합한 용매를 적용하는 경우 가장 높은 추출량으로, 총 폴리페놀 함량 93.75 mg/g, 총 플라보노이드 함량 16.80 mg/g을 나타내어 추출량이 현저히 높아지는 것을 확인할 수 있었다.As shown in Tables 3 and 4, it was confirmed that excellent extraction efficiency was exhibited when ethanol, acetone and chloroform were applied as extraction solvents. Furthermore, when a solvent mixed with acetone and chloroform in a volume ratio of 1:1 is applied as the extraction solvent, the extraction amount is significantly increased by showing the highest extraction amount, 93.75 mg/g of total polyphenol content, and 16.80 mg/g of total flavonoid content. could confirm that

<실시예 3> 유백피 추출물의 제조-3<Example 3> Preparation of milk white skin extract-3

유백피를 준비하여 동결건조 시킨 후, 믹서기로 갈아서 유백피 분말을 준비하였다. After preparing the milk white skin and freeze-drying it, it was ground with a blender to prepare milk white skin powder.

준비된 유백피 분말 0.05 g와 공융 용매 0.01-1.00 g을 아세톤 및 클로로포름을 1:1의 부피비율로 혼합한 용매 5 ml에 첨가하였다.0.05 g of the prepared milk powder and 0.01-1.00 g of the eutectic solvent were added to 5 ml of a solvent in which acetone and chloroform were mixed in a volume ratio of 1:1.

이후, 초음파공정을 수행하여 30℃의 온도에서 24시간 동안 추출한 후, 여과지(Watman No. 2)로 여과한 뒤 농축기(EYELA N-3000, Japan)로 55℃에서 감압농축 및 동결건조하여 추출물을 얻었다. 실시예 3에서 수행된 유백피 추출의 조건은 하기 표 5에 나타내었다.Then, after performing an ultrasonic process to extract at a temperature of 30 ℃ for 24 hours, filtered with filter paper (Watman No. 2), concentrated under reduced pressure at 55 ℃ with a concentrator (EYELA N-3000, Japan) and freeze-dried to extract the extract got it The conditions for the extraction of milk white skin carried out in Example 3 are shown in Table 5 below.

제조된 유백피 추출물의 총 폴리페놀 함량, 총 플라보노이드 함량을 분석하였으며, 구체적으로, 총 폴리페놀 함량은 Folin-Denis법을 응용하여 측정하였으며, 총 플라보노이드 함량은 Nieva Moreno 방법을 응용하여 측정하였고 그 결과를 하기 표 6에 나타내었다.The total polyphenol content and total flavonoid content of the prepared milkweed extract were analyzed. Specifically, the total polyphenol content was measured by applying the Folin-Denis method, and the total flavonoid content was measured by applying the Nieva Moreno method. is shown in Table 6 below.

실시예 3Example 3 공융용매eutectic solvent 염:수소결합주개 몰비Salt: hydrogen bond donor molar ratio 공융용매 첨가량 (g)
Amount of eutectic solvent added (g)
salt 수소결합주개hydrogen bond donor 실시예 3-1Example 3-1 콜린클로라이드Choline Chloride 에틸렌글리콜ethylene glycol 1:41:4 0.010.01 실시예 3-2Example 3-2 테트라메틸암모늄 클로라이드tetramethylammonium chloride 에틸렌글리콜ethylene glycol 1:41:4 0.010.01 실시예 3-3Example 3-3 메틸 트리페닐 포스포늄 브로마이드Methyl triphenyl phosphonium bromide 에틸렌글리콜ethylene glycol 1:41:4 0.010.01 실시예 3-4Example 3-4 콜린클로라이드Choline Chloride 1,2-부탄디올1,2-Butanediol 1:21:2 0.010.01 실시예 3-5Example 3-5 콜린클로라이드Choline Chloride 우레아urea 1:21:2 0.010.01 실시예 3-6Example 3-6 콜린클로라이드Choline Chloride 에틸렌글리콜ethylene glycol 1:41:4 0.050.05 실시예 3-7Example 3-7 0.10.1 실시예 3-8Example 3-8 0.20.2 실시예 3-9Example 3-9 0.30.3 실시예 3-10Example 3-10 0.40.4 실시예 3-11Example 3-11 0.60.6 실시예 3-12Example 3-12 1.01.0

실시예 3Example 3 총 폴리페놀 함량
(mg/g)
Total polyphenol content
(mg/g)
총 플라보노이드 함량
(mg/g)
Total flavonoid content
(mg/g)
실시예 3-1Example 3-1 95.8095.80 18.2518.25 실시예 3-2Example 3-2 93.8593.85 16.9516.95 실시예 3-3Example 3-3 92.5492.54 16.5716.57 실시예 3-4Example 3-4 94.6994.69 17.2017.20 실시예 3-5Example 3-5 93.9593.95 17.0217.02 실시예 3-6Example 3-6 100.27100.27 19.8719.87 실시예 3-7Example 3-7 110.75110.75 20.4320.43 실시예 3-8Example 3-8 124.05124.05 20.9820.98 실시예 3-9Example 3-9 136.60136.60 21.3021.30 실시예 3-10Example 3-10 146.23146.23 22.4722.47 실시예 3-11Example 3-11 167.54167.54 25.3125.31 실시예 3-12Example 3-12 152.65152.65 23.0123.01

상기 표 5 및 표 6에 나타낸 바와 같이, 공융용매를 적용하는 경우 더욱 우수한 추출효율을 나타냄을 확인할 수 있었다. 특히, 공융용매로 콜린클로라이드 및 에틸렌글리콜을 1:4의 몰비로 적용한 공융용매를 0.6 g 사용하는 경우 총 폴리페놀 함량 167.54 mg/g, 총 플라보노이드 함량 25.31 mg/g을 나타내어 추출량이 현저히 높아지는 것을 확인할 수 있었다.As shown in Tables 5 and 6, it was confirmed that the extraction efficiency was more excellent when the eutectic solvent was applied. In particular, when 0.6 g of a eutectic solvent in which choline chloride and ethylene glycol are applied in a molar ratio of 1:4 as the eutectic solvent is used, the total polyphenol content is 167.54 mg/g and the total flavonoid content is 25.31 mg/g, indicating that the extraction amount is significantly increased. could

이상, 본 발명내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적인 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의해 정의된다고 할 것이다.Above, a specific part of the present invention has been described in detail, for those of ordinary skill in the art, it is clear that this specific description is only a preferred embodiment, and the scope of the present invention is not limited thereby. something to do. Accordingly, it is intended that the substantial scope of the present invention be defined by the appended claims and their equivalents.

Claims (3)

유백피를 준비하는 단계;
준비된 유백피를 아세톤 및 클로로포름을 1:1의 부피비로 혼합한 유기 용매 및 염으로 콜린클로라이드 및 수소결합주개로 에틸렌글리콜을 1:4의 몰비로 혼합한 공융 용매와 혼합하되, 공융 용매의 함량은 유기 용매 1 ml에 대하여 0.12 g을 사용하여 초음파공정으로 30℃의 온도에서 24시간 동안 유효성분을 포함하는 용액을 추출하는 단계; 및
추출된 용액을 감압농축 및 동결건조하여 유백피 추출물을 제조하되, 상기 유백피 추출물은 총 폴리페놀 함량이 167.54 mg/g이고, 총 플라보노이드 함량이 25.31 mg/g인 것을 특징으로 하는 단계;를 포함하는 유백피 추출물의 제조방법.
Preparing milk white blood;
The prepared milkweed is mixed with an organic solvent in which acetone and chloroform are mixed in a volume ratio of 1:1, and a eutectic solvent in which choline chloride and ethylene glycol are mixed with a hydrogen bond donor in a molar ratio of 1:4 as a salt, but the content of the eutectic solvent is Extracting a solution containing the active ingredient for 24 hours at a temperature of 30 ℃ by ultrasonication using 0.12 g with respect to 1 ml of the organic solvent; and
Concentrating and freeze-drying the extracted solution under reduced pressure to prepare a milkweed extract, wherein the milkweed extract has a total polyphenol content of 167.54 mg/g and a total flavonoid content of 25.31 mg/g; including; A method for producing a milkweed extract.
삭제delete 삭제delete
KR1020220081702A 2022-07-04 2022-07-04 Method for extracting active ingredients from Ulmi Cortex KR102450185B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020220081702A KR102450185B1 (en) 2022-07-04 2022-07-04 Method for extracting active ingredients from Ulmi Cortex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020220081702A KR102450185B1 (en) 2022-07-04 2022-07-04 Method for extracting active ingredients from Ulmi Cortex

Publications (1)

Publication Number Publication Date
KR102450185B1 true KR102450185B1 (en) 2022-09-30

Family

ID=83451679

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220081702A KR102450185B1 (en) 2022-07-04 2022-07-04 Method for extracting active ingredients from Ulmi Cortex

Country Status (1)

Country Link
KR (1) KR102450185B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180106104A (en) 2017-03-17 2018-10-01 단국대학교 천안캠퍼스 산학협력단 Composition for antiinflammatory and inflammatory neurodegenerative diseases comprising ulmi cortex extract
KR20190032677A (en) * 2017-09-18 2019-03-28 한국 한의학 연구원 Pharmaceutical Compositions for preventing or treating memory impairment or memory disorder comprising extract of Ulmi Cortex as an active ingredient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180106104A (en) 2017-03-17 2018-10-01 단국대학교 천안캠퍼스 산학협력단 Composition for antiinflammatory and inflammatory neurodegenerative diseases comprising ulmi cortex extract
KR20190032677A (en) * 2017-09-18 2019-03-28 한국 한의학 연구원 Pharmaceutical Compositions for preventing or treating memory impairment or memory disorder comprising extract of Ulmi Cortex as an active ingredient

Similar Documents

Publication Publication Date Title
Patel Yucca: A medicinally significant genus with manifold therapeutic attributes
US20190008907A1 (en) Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases
KR102124592B1 (en) Hand-disinfectant composition for antibacterial and antivirus containing the extracts of natural material
EP2632475B1 (en) Compositions for the treatment of peripheral ulcers of various origins
KR20150013162A (en) Topical pharmaceutical compositions comprising terbinafine and urea
KR102187285B1 (en) Composition For Improving of Scalp and Hair Condition Comprising Agaricus blazei Murill, Inonotus Obliquus, Grifola frondosa, Phellinus linteus and Sparasis crispa as Active Ingredient
KR102450185B1 (en) Method for extracting active ingredients from Ulmi Cortex
Sipping et al. Antioxidant and anti-inflammatory activities of Ganoderma resinaceum (Boud) fruiting bodies extracts
KR101817941B1 (en) Cosmetic compositions for skin-improvement having anti-atopic efficacy comprising Rubus crataegifolius leaf extraction as an efficient component
KR102446734B1 (en) Method for extracting active ingredients from Chaenomelis Fructus
KR102446729B1 (en) Method for extracting active ingredients from rubus coreanus miquel fruits
CN113456594B (en) Method for preparing liposome containing glycyrrhiza inflata extract and madecassoside
RU2494757C1 (en) Pharmaceutical composition containing enzyme deoxyribonuclease, alpha-fetoprotein and glycyrrhizic acid or salts thereof: ammonium or dipotassium or trisodium glycyrrhizinate
KR102435822B1 (en) Method for extracting active ingredients from Citrus grandis osbeck
KR102434750B1 (en) Method for extracting active ingredients from Arctium lappa L
CN112206316B (en) Medical ray protective agent and preparation method thereof
CN105748545B (en) Application of Notoginseng radix converted saponin in preparing medicine for resisting fungi such as Epidermophyton floccosum, Trichophyton rubrum and Trichophyton mentagrophytes
Kumar et al. A Review On Therapeutic Potential Of Punica Granatum.
KR102428008B1 (en) Method for extracting active ingredients from eckloina cava
KR102437741B1 (en) Method for extracting active ingredients from Lycium barbarum
WO2019048738A1 (en) Extract, pharmaceutical and therapeutical use thereof and method for the production thereof
KR102439791B1 (en) Method for extracting active ingredients from rubus coreanus miquel fruits
KR101938360B1 (en) Composition for enhancing and maintaining skin permeability
KR102171200B1 (en) Composition for the treatment or improvement of Acne dermatitis comprising 5-aminolevulinic acid hydrochloride and its derivatives
Pascale et al. Therapeutical Properties of Bioactive Compounds Extracted from Ganoderma lucidum Species on Acute and Chronic Diseases

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant